KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Change in Intangibles (2016 - 2025)

Historic Change in Intangibles for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to -$601.2 million.

  • Gsk's Change in Intangibles fell 294.22% to -$601.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.2 billion, marking a year-over-year decrease of 1693.41%. This contributed to the annual value of -$2.2 billion for FY2025, which is 668.41% down from last year.
  • Per Gsk's latest filing, its Change in Intangibles stood at -$601.2 million for Q4 2025, which was down 294.22% from -$766.3 million recorded in Q3 2025.
  • Gsk's 5-year Change in Intangibles high stood at -$176.7 million for Q2 2024, and its period low was -$2.3 billion during Q4 2021.
  • Its 5-year average for Change in Intangibles is -$590.6 million, with a median of -$504.4 million in 2022.
  • In the last 5 years, Gsk's Change in Intangibles tumbled by 20157.14% in 2021 and then skyrocketed by 8256.18% in 2022.
  • Quarter analysis of 5 years shows Gsk's Change in Intangibles stood at -$2.3 billion in 2021, then skyrocketed by 69.52% to -$700.2 million in 2022, then rose by 5.17% to -$664.0 million in 2023, then rose by 12.05% to -$584.0 million in 2024, then fell by 2.94% to -$601.2 million in 2025.
  • Its last three reported values are -$601.2 million in Q4 2025, -$766.3 million for Q3 2025, and -$502.9 million during Q2 2025.